Career history of Tami Rachmilewitz
Former positions of Tami Rachmilewitz
| Companies | Position | Start | End |
|---|---|---|---|
| BIOLINERX LTD. | Chief Tech/Sci/R&D Officer | 03/01/2023 | 30/09/2023 |
| NOTABLE LABS, LTD. | Chief Tech/Sci/R&D Officer | 31/05/2018 | 30/11/2022 |
| NEURODERM LTD | Chief Tech/Sci/R&D Officer | 31/12/2015 | 31/12/2017 |
Training of Tami Rachmilewitz
| The Hebrew University Hadassah Medical School | Doctorate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
Statistics
International
| Israel | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BIOLINERX LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
- Stock Market
- Insiders
- Tami Rachmilewitz
- Experience
